Company / Inventory
Exelixis Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$21.7M
FY2025
5-year range
$17.3M / $33.3M
FY2021-FY2025
Trend
-3.1%
vs FY2024
Sector context
#78 of 105
Health Care
What the data says
At $22M, Exelixis's inventory ranks #78 of 105 in the Health Care sector. Inventory has fluctuated over the past 10 years, ranging from $3M in FY2016 to $33M in FY2022.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +0.7%.
Improved from $17M to $22M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -13.3%
- 5-Year CAGR
- +0.7%
- 10-Year CAGR
- -
Sector benchmark
#78 of 105 in Health CareTop 74% of 105This company $21.7M Sector average $885.3M
▼
-97.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.7%, indicating consistent growth.
- In FY2025, inventory decreased 3.1% year-over-year.
- Ranks #78 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.7M | -3.1% |
| FY2024 | $22.4M | +29.2% |
| FY2023 | $17.3M | -48.0% |
| FY2022 | $33.3M | +21.1% |
| FY2021 | $27.5M | +31.1% |
| FY2020 | $21.0M | +62.8% |
| FY2019 | $12.9M | +31.0% |
| FY2018 | $9.8M | +47.8% |
| FY2017 | $6.7M | +99.4% |
| FY2016 | $3.3M | +27.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026